CTTH - CTT Pharmaceutical Holdings, Inc.
| Previous Close | 0.1699 |
| Open | 0.1550 |
| Bid | 0.0000 x 0 |
| Ask | 0.0000 x 0 |
| Day's Range | 0.1202 - 0.1550 |
| 52 Week Range | 0.1100 - 0.5800 |
| Volume | 69,528 |
| Avg. Volume | 34,013 |
| Market Cap | 16.752M |
| Beta (5Y Monthly) | 1.16 |
| PE Ratio (TTM) | N/A |
| EPS (TTM) | -0.0800 |
| Earnings Date | N/A |
| Forward Dividend & Yield | N/A (N/A) |
| Ex-Dividend Date | N/A |
| 1y Target Est | N/A |
- PR Newswire
CTT Pharmaceuticals provides Corporate Update
CTT Pharmaceutical Holdings, Inc., (the "Company" or "CTT") (OTC: CTTH), an innovative life sciences company with a portfolio of IP in novel drug delivery systems, today provides an update on the successful commercial introduction of its sublingual strips with Aurora Cannabis and intentions for product portfolio expansion.
- CNW Group
Aurora Cannabis Provides Corporate Update and Confirms Cannabis 2.0 Roll Out
EDMONTON , Dec. 23, 2019 /CNW/ - Aurora Cannabis Inc. (the "Company" or "Aurora") (NYSE | TSX: ACB), the Canadian company defining the future of cannabis worldwide, today provided an update on the readiness of its operations with the introduction of new product formats, recent industry recognitions and updates to existing operations. As a global leader in cannabis revenues, cannabis production, research, innovation and international market development, the Company intends to provide regular updates to its stakeholders in an effort to demonstrate continued transparency and disclosure.
- CNW Group
Aurora Cannabis Announces Change to Executive Team: Cam Battley Steps Away From his Role as Chief Corporate Officer
EDMONTON , Dec. 21, 2019 /CNW/ - Aurora Cannabis Inc. (the "Company" or "Aurora") (NYSE │ TSX: ACB), the Canadian company defining the future of cannabis worldwide, announces a change to the Executive Team. Cam Battley has stepped down as Chief Corporate Officer effective December 20, 2019 . Mr. Battley joined Aurora in 2016, serving a number of senior roles critical to the success of the company in its early years before being named Chief Corporate Officer in 2018.
- CNW Group
Aurora Cannabis Achieves Highest Cannabis Corporate Boards Ranking in 2019 Globe & Mail Board Games Report
EDMONTON , Dec. 2, 2019 /CNW/ - Aurora Cannabis Inc. (the "Company" or "Aurora") (NYSE │ TSX: ACB), the Canadian company defining the future of cannabis worldwide, is pleased to acknowledge the Company's ranking in the 2019 annual Report on Business ("ROB") review of Corporate Boards, known as Board Games. Published in its 18th year, the ROB Board Games considers dozens of governance criteria, extending beyond those required by formal regulations.
- CNW Group
Aurora Receives First Approval for Medicinal Cannabis Product in Ireland
EDMONTON , Dec. 2, 2019 /CNW/ - Aurora Cannabis Inc. (the "Company" or "Aurora") (NYSE │ TSX: ACB), the Canadian company defining the future of cannabis worldwide, today announced that one of the Company's oil products has now been approved for use under Ireland's new Medical Cannabis Access Programme (MCAP). Aurora's High CBD Oil Drops received approval from the Irish authorities and have now been added to a regulatory schedule by the Irish Minister of Health enabling importation, prescribing and supply under the scheme and is to date, one of only two products to gain such authorization.
CNW GroupAurora Cannabis Opens Experiential Flagship Store in North America's Largest Mall
EDMONTON , Nov. 27, 2019 /CNW/ - Aurora Cannabis Inc. ("Aurora") (NYSE | TSX: ACB), the Canadian company defining the future of cannabis worldwide, today announced the grand opening of its flagship retail store at 10:00 a.m. MT on November 27 th in the West Edmonton Mall, North America's largest mall. At approximately 11,000 square feet, Aurora has combined both a retail cannabis store and an immersive experiential space, encouraging visitors from around the world to explore unique products and participate in a rotating calendar of programming and events. Aurora's flagship store offers visitors a safe, age-gated retail experience in full compliance with all relevant federal and provincial regulations.
- CNW Group
CTT Pharma Strengthens Board and Management Team
HAMILTON, ON , Nov. 27, 2019 /CNW/ - CTT Pharmaceutical Holdings, Inc., (the "Company" or "CTT") (CTTH), an innovative life sciences company with a portfolio of IP in novel drug delivery systems, announced today several additions to its Board of Directors and management team. Effective immediately, Robert (Bob) Allen has been appointed CFO, Dana Buschmann has been appointed Director (Independent), and Marc Lakmaaker has been named strategic advisor to the Company.
- CNW Group
Aurora Cannabis Announces Pricing of Early Amended Conversion Privilege for Convertible Debentures
Aurora Cannabis Announces Pricing of Early Amended Conversion Privilege for Convertible Debentures
- CNW Group
View from the C-Suite: Glen Ibbott, Chief Financial Officer, Aurora Cannabis Inc., tells his company's story. Filmed on October 16, 2019
View from the C-Suite: Glen Ibbott, Chief Financial Officer, Aurora Cannabis Inc., tells his company's story. Filmed on October 16, 2019
- CNW Group
Aurora Cannabis Strengthens Leadership Team Adding Chief Product Officer and Chief Integration Officer
Aurora Cannabis Strengthens Leadership Team Adding Chief Product Officer and Chief Integration Officer
- CNW Group
Aurora Cannabis Provides Preliminary Update on Convertible Debenture Temporary Early Amended Conversion Privilege
EDMONTON , Nov. 19, 2019 /CNW/ - Aurora Cannabis Inc. (the "Company" or "Aurora") (NYSE │ TSX: ACB), the Canadian company defining the future of cannabis worldwide, announced today that the Company has received notice from holders of the Company's CAD $230 million 5% unsecured, convertible debentures due March 9, 2020 (the "Debentures"), representing approximately CAD $216 million principal amount, or approximately 94%, of the Debentures, voluntarily electing to convert their Debentures pursuant to the alternate settlement procedures as outlined in the indenture dated March 9, 2018 , as supplemented by the first supplemental indenture dated November 14, 2019 , between the Company and Computershare Trust Company of Canada (the "Supplemented Indenture"). The Company will issue a press release on November 22, 2019 after the close of trading of the stock exchanges, confirming the Amended Early Conversion Price (as defined in the Supplemented Indenture) and the Amended Early Conversion Ratio (as defined in the Supplemented Indenture).
- CNW Group
Aurora Cannabis Announces Temporary Amended Early Conversion Privilege for its 2020 Convertible Debentures
TORONTO , Nov. 14, 2019 /CNW/ - Aurora Cannabis Inc. ("Aurora" or the "Company") (NYSE | TSX: ACB), the Canadian company defining the future of cannabis worldwide, announced today that it has provided notice to all holders (the "Debentureholders") of the Company's CAD$230 million 5% unsecured, convertible debentures due March 9, 2020 (the "Debentures") of an opportunity to voluntarily convert their Debentures at the Amended Early Conversion Ratio (as defined herein). All Debentureholders will be able to convert their Debentures at the Amended Early Conversion Ratio during the period commencing on November 18, 2019 and ending at 5:00 p.m. ( Toronto time) on November 20, 2019 (the "Early Conversion Period").
- CNW Group
Aurora Cannabis Announces First Quarter 2020 Results & Corporate Action Plan
Aurora Cannabis Announces First Quarter 2020 Results & Corporate Action Plan
- CNW Group
Aurora Cannabis Announces 2019 AGM Voting Results
Aurora Cannabis Announces 2019 AGM Voting Results
- CNW Group
Aurora Cannabis to Host First Quarter 2020 Investor Conference Call
Aurora Cannabis to Host First Quarter 2020 Investor Conference Call
CNW GroupAurora Cannabis Launches National Safety Campaign on Edibles
Aurora Cannabis Launches National Safety Campaign on Edibles
- CNW Group
Consumer Legalization One Year Later: Aurora Cannabis Reveals Sneak Peek of Plans for NextGen Cannabis Products
EDMONTON , Oct. 16, 2019 /CNW/ - On the one-year anniversary of consumer legalization in Canada , Aurora Cannabis Inc. ("Aurora") (NYSE | TSX: ACB), the Canadian company defining the future of cannabis worldwide, announced plans for the roll-out of vapes, concentrates, and edibles when they are permitted for sale to consumers in December. The Company has prioritized its resources to prepare for a successful initial launch that will support an ongoing replenishment strategy to help ensure consumers across Canada will have access to a diverse portfolio of high-quality derivative products they want to buy. Photos are available on Aurora's Investor website HERE.
CNW GroupAurora Cannabis and CTT Pharmaceutical Announce Launch of Sublingual Cannabis Wafers
EDMONTON and HAMILTON, ON , Oct. 8, 2019 /CNW/ - Aurora Cannabis Inc. ("Aurora") (NYSE | TSX: ACB), the Canadian company defining the future of cannabis worldwide, and CTT Pharmaceutical Holdings, Inc., ("CTT") (OTC | CTTH) announced today the successful commercialization of CTT's cannabinoid-infused sublingual wafers. The new cannabis product line, a first of its kind, has been launched by Aurora in the Canadian medical cannabis market under the brand name "Dissolve Strips™".
CNW GroupAurora Cannabis Provides Update on Global Operations and Growth Initiatives
EDMONTON , Oct. 3, 2019 /CNW/ - Aurora Cannabis Inc. (the "Company" or "Aurora") (NYSE | TSX: ACB), the Canadian company defining the future of cannabis worldwide, today provided a corporate update on its global operations, business units, and portfolio of strategic investments. As a global leader in cannabis revenues, cannabis production, research, innovation, and international market development, the Company will provide regular, quarterly updates to its stakeholders in an effort to demonstrate continued transparency and disclosure. The Company also launched today, Aurora Insider, an investor focused blog which will provide regular updates and insight into the operations at Aurora.
- CNW Group
Aurora Cannabis Announces Date of Annual General Meeting
Aurora Cannabis Announces Date of Annual General Meeting
- CNW Group
Aurora Cannabis Announces Financial Results for the Fourth Quarter and 2019 Fiscal Year
Aurora Cannabis Announces Financial Results for the Fourth Quarter and 2019 Fiscal Year
- CNW Group
Aurora Cannabis Closes Expanded C$360 Million (US$280 Million) Credit Facility
Aurora Cannabis Closes Expanded C$360 Million (US$280 Million) Credit Facility
- CNW Group
Aurora Cannabis Announces Sale of Remaining Shares in The Green Organic Dutchman Sale of Non-Core Holdings Raises Gross Proceeds of $86.5 Million
Aurora Cannabis Announces Sale of Remaining Shares in The Green Organic Dutchman Sale of Non-Core Holdings Raises Gross Proceeds of $86.5 Million